Selected Talks

The Brigham Renal Board Review Course
Boston, MA; August, 2015
AKI Syndromes
Sushrut S. Waikar, MD
Dialysis Vascular Access - Part-02
Dirk Hentschel, MD
Dialysis Vascular Access - Part-01
Dirk Hentschel, MD
Take Home Messages - Transplantation
Anil Chandraker MD
Late Post-Transplant Medical Complications
Leonardo V. Riella, MD
Coronary Artery Disease and Renal Disease: Part-02
David M. Charytan, MD
Coronary Artery Disease and Renal Disease: Part-01
David M. Charytan, MD

  
The Brigham Renal Board Review Course major objective is to prepare participants for the ABIM Subspecialty Board Examination in Nephrology (Certification/Re-Certification). It conveys state-of-theart information on the pathophysiology, diagnosis, and management of renal disorders. The program also addresses fluid and electrolyte problems, hypertension, renal disease, and the management of acute and chronic renal failure. Additionally, the activity emphasizes the practical application of physiological principles to the understanding and management of clinical problems.

HDCN is pleased to present a selection of a number of presentations from this annual course. For more information on future courses, which take place every summer in Boston, usually in August, please click here.
See Individual Lecture Pages
This educational activity is an audio recording with accompanying slides of a live presentation held in August, 2015 in Boston, MA. The presentation was prepared under CME guidelines but no CME credit is available for this particular Web archive.

Release Date: May 01, 2016
To participate in this educational activity, the user will need Windows (XP or higher) or Macintosh (version 9.0 or higher) operating software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have an audio card with speakers. An audio player, either the Windows Media Player (downloadable from www.microsoft.com) the Real Player from Real Media (www.real.com) is required and either can be downloaded for free per instructions on the individual lecture pages. Flash 8.0 (from www.adobe.com) is required to see the full-screen slide/audio presentations and the video presentations.

 
SPONSORSHIP/SUPPORT:

None


SPEAKER DISCLOSURE STATEMENT and OFF-LABEL USE:

Disclosure Policy
Harvard Medical School has long held the standard that its continuing medical education courses are free of commercial bias.

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council on Continuing Medical Education, speakers, course planners, and content reviewers have been asked to disclose any relationship they, or their spouse or partner, have to companies producing pharmaceuticals, medical equipment or devices. In addition, faculty have been asked to list any off label uses they will discuss of pharmaceuticals and devices for investigatioal and non-FDA approved purposes.

Such dislcose is not intended to suggest or condone bias in any presentation, but is elicited to provide the course director and registrants with information that might be of potential importance to their evaluation of a given talk.


Off-label/lnvestigational Use
Because this course is meant to educate physicians with what is currently in use and what may be available in the future, there may be "off-label" use discussed in the presentations. Speakers have been requested to inform the audience when off-label use is being discussed. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program. The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, Harvard Medical School or the Brigham Hospital. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses. Before prescribing any medicine, primary references and full prescribing information should be consulted.

POLICY STATEMENTS:

The policy statements of HDCN related to posting of educational content are listed on this page.

For more information about the Harvard Renal Review Course, please see this link.